| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 45,206 | 44,087 | 36,543 | 49,095 | | Cost of Revenue | 33,095 | 31,456 | 27,242 | 36,850 | | | Gross Profit | 12,111 | 12,631 | 9,301 | 12,245 | | | Operating Expenses | | Research Development | 2,436 | 2,330 | 2,098 | 2,987 | | Selling General and Administrative | 9,704 | 10,630 | 10,550 | 12,567 | | Non Recurring | 8,361 |
-
| (1,529) | (4,965) | | Others | 622 | 622 | 622 | 820 | | | | Total Operating Expenses | 21,123 |
-
| 11,741 | 11,409 | | | | Operating Income or Loss | (651) | (951) | (2,440) | 836 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,846 | (415) | 398 | 622 | | Earnings Before Interest And Taxes | (1,166) | (1,366) | (2,042) | 1,458 | | Interest Expense | 170 | 13 | 18 | 30 | | Income Before Tax | (1,336) | (1,379) | (2,060) | 1,428 | | Income Tax Expense | (1,047) | (45) | 643 | 526 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (289) | (1,334) | (2,703) | 902 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (289) | (1,334) | (2,703) | 902 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($289) | ($1,334) | ($2,703) | $902 |
|
0.51% Nasdaq 
Income Statement
